# Second Pharma Co., Ltd., Shaoxing, China – FDA Inspections

Source: https://www.keypedia.com/companies/second-pharma-co-ltd/8edb6004-77bb-46b8-9347-b7df0bdb670f

> Inspection records and compliance data for Second Pharma Co., Ltd. in Shaoxing. 5 FDA inspections on record, 1 Form 483, last inspected August 30, 2024.

---

## Details

- Name: Second Pharma Co., Ltd.
- FEI Number: 3004836637
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK, REPACK
- Address Line 1: Hangzhou Gulf Fine, No. 33 Hangzhouwan Wei Fifth Road; Xietangzhen Shangyu
- City: Shaoxing
- Country Name: China
- Address: Hangzhou Gulf Fine, No. 33 Hangzhouwan Wei Fifth Road; Xietangzhen Shangyu, Shaoxing, China
- Country: China

## Related Documents

- [483 - Second Pharma Co., Ltd. - 2024-08-30](https://www.keypedia.com/records/483/second-pharma-co-ltd/7360edfa-0c77-4ebb-b3f7-e1cbceabab56) — source: FDA, date: August 30, 2024
- FDA Inspection 1251702 - Second Pharma Co., Ltd. - 2024-08-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2024
- FDA Inspection 1251702 - Second Pharma Co., Ltd. - 2024-08-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2024
- FDA Inspection 1009109 - Second Pharma Co., Ltd. - 2017-03-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 17, 2017
- [FDA Inspection 1009109 - Second Pharma Co., Ltd. - 2017-03-17](https://www.keypedia.com/records/fda_inspections/second-pharma-co-ltd/742a2921-5f21-4fb1-a90a-60deffed682e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 17, 2017
- FDA Inspection 922789 - Second Pharma Co., Ltd. - 2015-03-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 27, 2015
- FDA Inspection 764309 - Second Pharma Co., Ltd. - 2012-01-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2012
- FDA Inspection 764309 - Second Pharma Co., Ltd. - 2012-01-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2012
- FDA Inspection 603519 - Second Pharma Co., Ltd. - 2009-07-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2009

## Related Companies

- [Halocarbon Life Sciences, LLC](https://www.keypedia.com/companies/halocarbon-life-sciences-llc/22b56b6b-8819-4f99-a714-1b385e813064)
- [AX Pharmaceutical Corporation](https://www.keypedia.com/companies/ax-pharmaceutical-corporation/edd09f02-a326-4fd4-9b78-0db6bd74b76d)
- [Pharma Nobis LLC](https://www.keypedia.com/companies/pharma-nobis-llc/65e636d3-cd04-456d-b82a-a681bb7bdb9e)
- [University of Iowa Pharmaceuticals (UIP)](https://www.keypedia.com/companies/university-of-iowa-pharmaceuticals-uip/02fb53f6-b096-4068-a52e-9e38cea7fa0d)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/511e2b34-f9c9-4059-b74d-d1cd59ed6678)
- [AndersonBrecon Inc.](https://www.keypedia.com/companies/andersonbrecon-inc/799f84ea-9114-456a-83f1-7edcd7eb4d2e)
- [Ecolab, Inc.](https://www.keypedia.com/companies/ecolab-inc/b1f974bf-f8ce-4704-bbe7-2b1cc3d35c03)
- [Avantor Performance Materials LLC](https://www.keypedia.com/companies/avantor-performance-materials-llc/0621b513-0f0f-438c-8d52-81b548eb0501)
- [Symrise, Inc](https://www.keypedia.com/companies/symrise-inc/3c94427e-fd36-4498-bcbd-148093d778bd)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)